Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Long-Term Investments (2016 - 2018)

Utah Medical Products (UTMD) has 7 years of Long-Term Investments data on record, last reported at $72000.0 in Q1 2018.

  • For Q1 2018, Long-Term Investments rose 12.5% year-over-year to $72000.0; the TTM value through Mar 2018 reached $72000.0, up 12.5%, while the annual FY2017 figure was $80000.0, 25.0% up from the prior year.
  • Long-Term Investments reached $72000.0 in Q1 2018 per UTMD's latest filing, down from $80000.0 in the prior quarter.
  • Across five years, Long-Term Investments topped out at $80000.0 in Q4 2017 and bottomed at $44000.0 in Q1 2016.
  • Average Long-Term Investments over 5 years is $59294.1, with a median of $56000.0 recorded in 2014.
  • Peak YoY movement for Long-Term Investments: decreased 23.73% in 2016, then surged 60.0% in 2017.
  • A 5-year view of Long-Term Investments shows it stood at $58000.0 in 2014, then decreased by 5.17% to $55000.0 in 2015, then grew by 16.36% to $64000.0 in 2016, then grew by 25.0% to $80000.0 in 2017, then fell by 10.0% to $72000.0 in 2018.
  • Per Business Quant database, its latest 3 readings for Long-Term Investments were $72000.0 in Q1 2018, $80000.0 in Q4 2017, and $78000.0 in Q3 2017.